JP2012520325A - プレバイオティックオリゴ糖 - Google Patents

プレバイオティックオリゴ糖 Download PDF

Info

Publication number
JP2012520325A
JP2012520325A JP2011554245A JP2011554245A JP2012520325A JP 2012520325 A JP2012520325 A JP 2012520325A JP 2011554245 A JP2011554245 A JP 2011554245A JP 2011554245 A JP2011554245 A JP 2011554245A JP 2012520325 A JP2012520325 A JP 2012520325A
Authority
JP
Japan
Prior art keywords
composition
galactooligosaccharide
weight
less
bifidobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011554245A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012520325A5 (https=
Inventor
マリアナ バルボサ
ジェイ． ブルース ジャーマン
カーリト ビー． レブリラ
デビッド エー． ミルズ
サマラ フリーマン
ウィリアム ロバート キング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42728831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2012520325(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of California filed Critical University of California
Publication of JP2012520325A publication Critical patent/JP2012520325A/ja
Publication of JP2012520325A5 publication Critical patent/JP2012520325A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pediatric Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011554245A 2009-03-13 2010-03-12 プレバイオティックオリゴ糖 Pending JP2012520325A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16008809P 2009-03-13 2009-03-13
US61/160,088 2009-03-13
PCT/US2010/027206 WO2010105207A1 (en) 2009-03-13 2010-03-12 Prebiotic oligosaccharides

Publications (2)

Publication Number Publication Date
JP2012520325A true JP2012520325A (ja) 2012-09-06
JP2012520325A5 JP2012520325A5 (https=) 2013-04-25

Family

ID=42728831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011554245A Pending JP2012520325A (ja) 2009-03-13 2010-03-12 プレバイオティックオリゴ糖

Country Status (7)

Country Link
US (3) US8425930B2 (https=)
EP (1) EP2405918B2 (https=)
JP (1) JP2012520325A (https=)
AU (1) AU2010223965A1 (https=)
CA (1) CA2760999A1 (https=)
NZ (1) NZ595174A (https=)
WO (1) WO2010105207A1 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019117212A1 (ja) * 2017-12-12 2019-06-20 森永乳業株式会社 ビフィドバクテリウム属細菌を有効成分とする組成物
JP2019528740A (ja) * 2016-09-19 2019-10-17 プロラクタ バイオサイエンス，インコーポレイテッド 精製ヒトミルクオリゴ糖組成物
JP2022538561A (ja) * 2019-07-01 2022-09-05 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
WO2022191320A1 (ja) * 2021-03-12 2022-09-15 森永乳業株式会社 組成物
JP2025085819A (ja) * 2021-06-03 2025-06-05 森永乳業株式会社 組成物
US12364721B2 (en) 2019-09-24 2025-07-22 Prolacta Bioscience, Inc. Compositions and methods for treatment of inflammatory and immune diseases

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7919092B2 (en) 2006-06-13 2011-04-05 Oncomed Pharmaceuticals, Inc. Antibodies to notch receptors
EP2125887A4 (en) 2007-01-24 2010-11-10 Oncomed Pharm Inc COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
US9132189B2 (en) 2008-07-08 2015-09-15 Oncomed Pharmaceuticals, Inc. Notch1 binding agents and methods of use thereof
CN104402998A (zh) 2008-07-08 2015-03-11 昂考梅德药品有限公司 分离的抗体
SG173832A1 (en) 2009-02-24 2011-09-29 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
MY197622A (en) 2010-12-31 2023-06-28 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
JP6129821B2 (ja) 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
DK2734210T3 (en) * 2011-07-22 2018-01-22 Abbott Lab GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
HK1202244A1 (en) * 2011-11-30 2015-09-25 里特制药股份有限公司 Prebiotic formulations and methods of use
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
MX381098B (es) 2013-03-15 2025-03-12 Cargill Inc Composiciones de carbohidratos.
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
WO2015132402A1 (en) * 2014-03-06 2015-09-11 Arla Foods Amba Lactose-reduced milk products containing galacto-oligosaccharides and monosaccharides and a method of production
MX383492B (es) 2014-07-01 2025-03-04 Probi Usa Inc Comprimidos probióticos bicapa de doble liberación.
BR112017000345B1 (pt) 2014-07-09 2022-04-26 Cadena Bio, Inc Composições de oligossacarídeo, métodos para produção das mesmas e produto alimentar
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3229595B1 (en) 2014-12-12 2021-02-03 The Regents of the University of California Reduction of milk glycans and their degradation products in the neonate gut
JP6722697B2 (ja) 2015-01-26 2020-07-15 カデナ・バイオ・インコーポレイテッド 動物飼料として使用するためのオリゴ糖組成物及びその生成方法
EP3862002A1 (en) 2015-01-26 2021-08-11 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
SG11201708635QA (en) * 2015-04-23 2017-11-29 Kaleido Biosciences Inc Microbiome regulators and related uses thereof
CN107771083A (zh) 2015-04-23 2018-03-06 卡莱多生物科技有限公司 聚糖治疗剂和治疗方法
US10751354B2 (en) 2015-09-14 2020-08-25 Glycom A/S Synthetic composition for microbiota modulation
CA2992497C (en) 2016-01-12 2020-12-22 Vitalus Nutrition Inc. Method for producing galactooligosaccharides from lactose
WO2019119102A1 (en) * 2017-12-22 2019-06-27 Vitalus Nutrition Inc. Method for producing galactooligosaccharides from lactose
US10337042B2 (en) 2016-01-12 2019-07-02 Vitalus Nutrition Inc. Method for producing galactooligosaccharides from lactose
US10857168B2 (en) * 2016-02-24 2020-12-08 Glycom A/S Synthetic composition for microbiota modulation
CA3017357A1 (en) 2016-03-11 2017-09-14 Evolve Biosystems, Inc. A transient commensal microorganism for improving gut health
WO2017190755A1 (en) * 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain
EP3478093A4 (en) * 2016-07-01 2020-03-04 Evolve Biosystems, Inc. METHOD FOR ELEVATING THE MATURATION OF THE MAMMAL IMMUNE SYSTEM
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
WO2018048305A1 (en) 2016-09-12 2018-03-15 Rijksuniversiteit Groningen Prebiotic branched galacto-oligosaccharides (gos)
EP3523030B1 (en) * 2016-10-07 2021-05-05 Boehringer Ingelheim Vetmedica GmbH Analysis system and method for testing a sample
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
CN111372477B (zh) * 2017-08-04 2024-05-24 雀巢产品有限公司 在含有gos的培养基中预调理的益生菌及其用途
EP3703705B1 (en) 2017-11-03 2024-05-15 DSM Nutritional Products, LLC Glucose-containing glycan preparations for use in the treatment of hyperammonaemia
KR102032799B1 (ko) * 2017-11-16 2019-10-17 고려대학교 산학협력단 해조류 유래 아가로트리오스의 제조방법 및 프리바이오틱로서의 용도
US11304966B2 (en) 2017-12-22 2022-04-19 Glycom A/S Composition comprising HMOs for preventing or reducing nociception
CN113164532A (zh) 2018-05-30 2021-07-23 进化生物系统股份有限公司 H5功能性长双歧杆菌婴儿亚种的组合物和使用方法
EP3598901A1 (de) * 2018-07-23 2020-01-29 optiferm GmbH Beta-galactosidase aus l. bulgaricus zur synthese von galactooligosacchariden in molke
US20210330687A1 (en) * 2018-09-06 2021-10-28 Frieslandcampina Nederland B.V. Bifidogenic hypoallergenic gos compositions and methods for providing the same involving beta-galactosidase from a strain of lactobacillus delbrueckii ssp bulgaricus
EP3646739A1 (en) 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides
US20220325307A1 (en) * 2018-12-03 2022-10-13 Dupont Nutrition Biosciences Aps Use of lactase to provide high gos fiber level and low lactose level
CN109880813B (zh) * 2019-03-20 2022-06-07 安徽大学 一种具有低聚半乳糖合成能力的β-葡萄糖苷酶及其表达菌株和应用
CN111849940B (zh) * 2020-07-28 2022-03-25 量子高科(广东)生物有限公司 一种β-半乳糖苷酶的制备方法及其应用
EP4101301A1 (de) * 2021-06-08 2022-12-14 DMK Deutsches Milchkontor GmbH Verfahren zur herstellung von galactooligosacchariden
US12156859B2 (en) 2021-12-20 2024-12-03 Tainnovation Inc. Methods of and compositions for treating obesity, obesity-related diseases or cancers using a N6-methyllysine/l-lysine mixture
CA3272017A1 (en) * 2022-11-22 2024-05-30 Fairlife, Llc PROCESS FOR THE PRODUCTION OF GALACTO-OLIGOSACCHARIDES
GB2628547A (en) 2023-03-27 2024-10-02 Univ Newcastle Probiotic and postbiotic compositions, products and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05236981A (ja) * 1992-02-28 1993-09-17 Ajinomoto Co Inc ガラクトオリゴ糖の製造方法
JP2007527199A (ja) * 2003-06-30 2007-09-27 クラサド インコーポレイテッド 新規のガラクトオリゴサッカライド組成物およびその調製法
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
DK1087668T3 (da) * 1998-06-17 2005-01-24 New Zealand Dairy Board Bioaktivt valleproteinhydrolysat
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
FR2844453B1 (fr) † 2002-09-13 2006-05-19 Agronomique Inst Nat Rech Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
EP1549151A1 (en) * 2002-10-11 2005-07-06 Wyeth Nutritional formulations containing synbiotic substances
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
US20060115465A1 (en) * 2004-10-29 2006-06-01 Macfarlane George Treatment of gastrointestinal disorders
US20070141678A1 (en) * 2005-12-19 2007-06-21 The Procter & Gamble Company Processes for purifying oligosaccharides
ES2373592T3 (es) * 2006-10-02 2012-02-06 Friesland Brands B.V. Inhibición de toxinas del cólera por galactooligosacáridos (gos).
WO2008153377A1 (en) † 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05236981A (ja) * 1992-02-28 1993-09-17 Ajinomoto Co Inc ガラクトオリゴ糖の製造方法
JP2007527199A (ja) * 2003-06-30 2007-09-27 クラサド インコーポレイテッド 新規のガラクトオリゴサッカライド組成物およびその調製法
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7510978B2 (ja) 2016-09-19 2024-07-04 プロラクタ バイオサイエンス，インコーポレイテッド 精製ヒトミルクオリゴ糖組成物
KR102821643B1 (ko) 2016-09-19 2025-06-18 프롤랙타 바이오사이언스, 인코포레이티드 정제된 인간 모유 올리고당 조성물
JP7143286B2 (ja) 2016-09-19 2022-09-28 プロラクタ バイオサイエンス，インコーポレイテッド 精製ヒトミルクオリゴ糖組成物
KR20230130667A (ko) * 2016-09-19 2023-09-12 프롤랙타 바이오사이언스, 인코포레이티드 정제된 인간 모유 올리고당 조성물
JP2019528740A (ja) * 2016-09-19 2019-10-17 プロラクタ バイオサイエンス，インコーポレイテッド 精製ヒトミルクオリゴ糖組成物
JP2023002512A (ja) * 2016-09-19 2023-01-10 プロラクタ バイオサイエンス，インコーポレイテッド 精製ヒトミルクオリゴ糖組成物
JPWO2019117212A1 (ja) * 2017-12-12 2020-12-03 森永乳業株式会社 ビフィドバクテリウム属細菌を有効成分とする組成物
WO2019117212A1 (ja) * 2017-12-12 2019-06-20 森永乳業株式会社 ビフィドバクテリウム属細菌を有効成分とする組成物
JP2022538561A (ja) * 2019-07-01 2022-09-05 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
JP7719729B2 (ja) 2019-07-01 2025-08-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
US12364721B2 (en) 2019-09-24 2025-07-22 Prolacta Bioscience, Inc. Compositions and methods for treatment of inflammatory and immune diseases
WO2022191320A1 (ja) * 2021-03-12 2022-09-15 森永乳業株式会社 組成物
JP2022139601A (ja) * 2021-03-12 2022-09-26 森永乳業株式会社 組成物
JP2025085819A (ja) * 2021-06-03 2025-06-05 森永乳業株式会社 組成物

Also Published As

Publication number Publication date
US8425930B2 (en) 2013-04-23
EP2405918A1 (en) 2012-01-18
EP2405918B1 (en) 2014-10-22
NZ595174A (en) 2013-04-26
US20100254949A1 (en) 2010-10-07
WO2010105207A1 (en) 2010-09-16
EP2405918A4 (en) 2013-01-09
EP2405918B2 (en) 2020-09-02
AU2010223965A1 (en) 2011-10-06
US20140037785A1 (en) 2014-02-06
US20170000811A1 (en) 2017-01-05
CA2760999A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
US8425930B2 (en) Prebiotic oligosaccharides
US10918653B2 (en) Bovine milk oligosaccharides
US8197872B2 (en) Human milk oligosaccharides to promote growth of beneficial gut bacteria
NL2007268C2 (en) Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US10165788B2 (en) Methods and compositions for improved digestion of milk oligosaccharides
JP2022020856A (ja) プレバイオティクスとしての、精製された２’－フコシルラクトース、３－フコシルラクトース、およびラクトジフコテトラオースの使用
TW201233334A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
US20250197436A1 (en) Galactooligosaccharide composition
US20250312388A1 (en) Bifidobacterium infantis formulations
WO2018048305A1 (en) Prebiotic branched galacto-oligosaccharides (gos)
Levantovsky et al. Nutritional requirements of bifidobacteria
WO2024201041A2 (en) Probiotic and postbiotic compositions, products and uses thereof
Mera et al. Biotechnological innovations in pro-, pre-, and synbiotics
CN119403457A (zh) 岩藻糖基化hmo的混合物
HK1260295A1 (en) Bovine milk oligosaccharides
Class et al. Patent application title: BOVINE MILK OLIGOSACCHARIDES Inventors: J. Bruce German (Davis, CA, US) J. Bruce German (Davis, CA, US) David Mills (Davis, CA, US) Carlito B. Lebrilla (Davis, CA, US) Carlito B. Lebrilla (Davis, CA, US) Daniela Barile (Davis, CA, US) Riccardo Locascio (Sacramento, CA, US)
Kumar Evaluation of Probiotic Effectiveness of Certain Functional Fibers
HK1242227A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
JP2016154511A (ja) 資化性菌のスクリーニング方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130306

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130306

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140723

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150122